How to buy AZIYO BIOLOGICS stock | 11.9

AZIYO BIOLOGICS, INC. is a medical devices business based in the US. AZIYO BIOLOGICS shares (AZYO) are listed on the NASDAQ and all prices are listed in US Dollars. AZIYO BIOLOGICS employs 150 staff and has a trailing 12-month revenue of around USD$41.6 million.

How to buy shares in AZIYO BIOLOGICS

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for AZIYO BIOLOGICS. Find the stock by name or ticker symbol: AZYO. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until AZIYO BIOLOGICS reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$11.9, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of AZIYO BIOLOGICS, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of AZIYO BIOLOGICS. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

AZIYO BIOLOGICS share price

Use our graph to track the performance of AZYO stocks over time.

AZIYO BIOLOGICS shares at a glance

• Key figures

Information last updated 2020-10-19.

Latest market close	USD$11.9
52-week range	USD$11.475 - USD$18
50-day moving average	USD$12.7143
200-day moving average	USD$12.7143
Wall St. target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy AZIYO BIOLOGICS stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of AZIYO BIOLOGICS, INC. by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AZIYO BIOLOGICS price performance over time

Historical closes compared with the close of $11.9 from 2020-10-19

1 week (2020-10-16)	-0.83%
1 month (2020-09-22)	N/A
3 months (2020-07-22)	N/A
6 months (2020-04-22)	N/A

1 year (2019-10-22)	N/A
2 years (2018-10-22)	N/A
3 years (2017-10-22)	N/A
5 years (2015-10-22)	N/A

AZIYO BIOLOGICS financials

Revenue TTM	USD$41.6 million
Gross profit TTM	USD$19.8 million
Return on assets TTM	0%
Return on equity TTM	0%
Profit margin	-37.53%
Book value	N/A
Market capitalisation	USD$123.4 million

TTM: trailing 12 months

AZIYO BIOLOGICS share dividends

We're not expecting AZIYO BIOLOGICS to pay a dividend over the next 12 months.

AZIYO BIOLOGICS overview

Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo, a biological envelope that remodels into vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic devices; and ProxiCor, Tyke, and VasCure, which are a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors, and proteins for use in vascular and cardiac repair, and pericardial closure. The company also provides FiberCel, ViBone, and OsterGro V that are viable matrices designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated human cellular dermal matrix designed to meet a range of surgical needs. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc. was founded in 2015 and is headquartered in Silver Spring, Maryland. It has additional offices in Roswell, Georgia; and Richmond, California

Frequently asked questions

• How many people work for AZIYO BIOLOGICS?

  Latest data suggests 150 work at AZIYO BIOLOGICS.

• When does the fiscal year end for AZIYO BIOLOGICS?

  AZIYO BIOLOGICS's fiscal year ends in December.

• Where is AZIYO BIOLOGICS based?

  AZIYO BIOLOGICS's address is: 12510 Prosperity Drive, Silver Spring, MD, United States, 20904